Notably, according to the analysis of the GEPIA2 database, ccRCC patients with high DGAT1 or DGAT2 expression (normalized by endoplasmic reticulum marker CANX) usually had a shorter survival time (Fig. 3D). The gene discussed is DGAT2; the disease is nonpapillary renal cell carcinoma.